Improved tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: the lercanidipine challenge trial. (Q44474376)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Improved tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: the lercanidipine challenge trial. |
scientific article |
Statements
Improved tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: the lercanidipine challenge trial (English)
Claudio Borghi
Maria Grazia Prandin
Ada Dormi
Ettore Ambrosioni
Study Group of the Regional Unit of the Italian Society of Hypertension